Haemophilus Influenzae type b Conjugate ... Clinical Trials

• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines, Each Administered at 2, 4, 6, and 12 to 15 Months of Age.
  ClinicalTrials.gov Identifier: NCT00134719 - Active, not recruiting
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Study to Eliminate Hib Carriage in Rural Alaska Native Villages
  ClinicalTrials.gov Identifier: NCT00153556 - Completed
  Haemophilus influenzae type B; Carrier State
  
• Immunogenicity and Safety of PENTAXIM™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00259337 - Active, not recruiting
  Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B
  
• Dose Ranging Study of 3 Formulations of Hib-MenCY-TT Vaccine and 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2, 3, and 4 Months of Age.
  ClinicalTrials.gov Identifier: NCT00129116 - Completed
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine, Each Administered at 2, 4, and 6 Months of Age; and Compared to Licensed Meningococcal Serogroups A, C, Y, and W-135 Polysaccharide Vaccine Administered at
  ClinicalTrials.gov Identifier: NCT00129129 - Completed
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Assess Reacto- & Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule
  ClinicalTrials.gov Identifier: NCT00513409 - Active, not recruiting
  Diseases Caused by Streptococcus Pneumoniae or Haemophilus Influenzae
  
• Immunogenicity & Safety Study to Evaluate the Response to a Booster Dose of GSK Biologicals'' Tritanrix™-HepB/Hib-MenAC Vaccine at 15-24 Months and to Evaluate the Response to Mencevax™ ACWY at 24-30 Months in Healthy Children Primed with
  ClinicalTrials.gov Identifier: NCT00136604 - Completed
  Prophylaxis diphtheria, tetanus, pertussis, hepatits B, Haemophilus influenzae type b and meningococcal serogroup A & C disease
  
• Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants
  ClinicalTrials.gov Identifier: NCT00401531 - Active, not recruiting
  Hepatitis B; Polio; Diphtheria; Pertussis; Haemophilus Influenzae Type B
  
• Study to Demonstrate the Lot-to-Lot Consistency of Hib-MenAC When Mixed with Tritanrix™-HepB, and to Demonstrate Its Non-Inferiority as Compared to Tritanrix™-HepB/Hiberix™ in Infants at 2, 4&6 m
  ClinicalTrials.gov Identifier: NCT00197275 - Completed
  Prophylaxis diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b and meningococcal serogroups A and C diseases
  
• Safety of DTaP-IPV-HB-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.
  ClinicalTrials.gov Identifier: NCT00313911 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type B; Hepatitis B
  
• Comparison of DTaP IPV HB PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
  ClinicalTrials.gov Identifier: NCT00362336 - Active, not recruiting
  Hepatitis B; Polio; Diphtheria; Pertussis; Haemophilus Influenzae Type B
  
• Dose Ranging Study of 3 Formulations of Hib-MenCY-TT Vaccine Compared to Licensed Hib and Meningococcal Serogroup C Vaccines, Each Administered at 2, 4, and 6 Months of Age.
  ClinicalTrials.gov Identifier: NCT00127855 - Completed
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age
  ClinicalTrials.gov Identifier: NCT00289913 - Recruiting
  Hepatitis A
  
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
  ClinicalTrials.gov Identifier: NCT00534833 - Recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type B
  
• To Assess Safety and Reactogenicity of GSK Biologicals'' Haemophilus Influenza Type b Vaccine Co-Administered with or Without Chinese DTPw Vaccine.
  ClinicalTrials.gov Identifier: NCT00158795 - Completed
  Prophylaxis of Haemophilus influenza type b disease
  
• Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines
  ClinicalTrials.gov Identifier: NCT00254917 - Active, not recruiting
  Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B
  
• Long-Term Persistence Study to Assess a Booster Dose of GSK Biologicals’ Hib-MenC
  ClinicalTrials.gov Identifier: NCT00322335 - Active, not recruiting
  Haemophilus Influenzae Type B; Meningococcal Serogroup C Diseases
  
• Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
  ClinicalTrials.gov Identifier: NCT00343421 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae Type B
  
• Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months
  ClinicalTrials.gov Identifier: NCT00453570 - Active, not recruiting
  Diphtheria; Tetanus; Haemophilus Influenzae Type B; Pertussis; Poliomyelitis
  
• The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine
  ClinicalTrials.gov Identifier: NCT00197782 - Completed
  Haemophilus Influenzae Type B
  
• Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
  ClinicalTrials.gov Identifier: NCT00287092 - Active, not recruiting
  Pertussis; Diphtheria; Tetanus; Poliomyelitis; Haemophilus Influenzae Type B
  
• Study of Anti-HIV Therapy Intensification
  ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
  HIV Infections
  
• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00289783 - Active, not recruiting
  Haemophilus Infections; Meningococcal Infections
  
• Safety & Immunogenicity of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 Months of Age.
  ClinicalTrials.gov Identifier: NCT00345579 - Active, not recruiting
  Haemophilus Infections; Meningococcal Infections
  
• Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00152802 - Active, not recruiting
  transplant
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects
  ClinicalTrials.gov Identifier: NCT00323050 - Completed
  H.Influenzae Type b Diseases; Meningococcal Serogroup C Diseases
  
• To Assess the Immune Memory Following Primary Vaccination with a Formulation of DTPw-HBV/Hib Vaccine and to Assess Immunogenicity and Reactogenicity of a Booster Dose Given at 15-18 Months of Age.
  ClinicalTrials.gov Identifier: NCT00158808 - Completed
  Prophylaxis of Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenza type b diseases
  
• Non-Inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib
  ClinicalTrials.gov Identifier: NCT00473668 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type b Diseases
  
• Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00500357 - Active, not recruiting
  Vaccines, Pneumococcal Conjugate Vaccine
  
• Study to Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00269672 - Active, not recruiting
  Vaccines, Pneumococcal Conjugate Vaccine
  
• Study Evaluating 13-Valent Pneumococal Conjugate Vaccine in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00475033 - Recruiting
  Vaccines, Pneumococcal Conjugate Vaccine
  
• To Evaluate Immunogenicity & Safety of GSK Bio’s DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines
  ClinicalTrials.gov Identifier: NCT00366366 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Polio; Haemophilus Influenzae Type B
  
• A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
  ClinicalTrials.gov Identifier: NCT00000829 - Active, not recruiting
  HIV Infections; Pneumococcal Infections
  
• Study Comparing 13 Valente Pneumococcal Conjugate Vaccine With 7 Valent Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00373958 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Primary & Booster Study in Infants to Demonstrate Non-Inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine.
  ClinicalTrials.gov Identifier: NCT00327184 - Active, not recruiting
  H.Influenzae Type b Disease; Meningococcal Serogroup C Diseases
  
• Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants
  ClinicalTrials.gov Identifier: NCT00574795 - Recruiting
  Vaccines, Pneumococcal Conjugate Vaccine
  
• Immunogenicity and Safety Study to Evaluate 2 Formulations of GSK Biologicals'' MenC-TT Vaccine and 2 Formulations of GSK Biologicals'' Hib-MenC-TT Vaccine in Infants in Their 3rd, 4th, 5th Months of Life
  ClinicalTrials.gov Identifier: NCT00135486 - Completed
  Prophylaxis meningococcal serogroup C disease, Hib diseases
  
• Prevention of GBS Colonization Via Immun
  ClinicalTrials.gov Identifier: NCT00128219 - Active, not recruiting
  Streptococcus group B
  
• COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & AOM Efficacy Study of the Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00466947 - Recruiting
  Pneumonia & AOM Caused by S. Pneumoniae & H. Influenzae
  
• Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.
  ClinicalTrials.gov Identifier: NCT00316680 - Completed
  Prophylaxis for Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type b Diseases
  
• Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine
  ClinicalTrials.gov Identifier: NCT00343889 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections
  
• Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella, and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month Old Children
  ClinicalTrials.gov Identifier: NCT00312858 - Active, not recruiting
  Hepatitis A
  
• Booster Study to Evaluate the Immunological Memory Induced by GSK Biologicals'' MenC-TT and 2 Formulations of GSK Biologicals'' Hib-MenC-TT or Meningitec™ in Healthy Toddlers Aged 12-15 Months Primed in Study 711202/001.
  ClinicalTrials.gov Identifier: NCT00135564 - Completed
  Prophylaxis meningococcal serogroup C disease, Hib diseases
  
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00013871 - Active, not recruiting
  HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis
  
• Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
  ClinicalTrials.gov Identifier: NCT00143780 - Active, not recruiting
  Bone Marrow Transplant
  
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
  ClinicalTrials.gov Identifier: NCT00325130 - Active, not recruiting
  Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
  
• Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults
  ClinicalTrials.gov Identifier: NCT00492557 - Active, not recruiting
  Pneumococcal Infections
  
• Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
  ClinicalTrials.gov Identifier: NCT00164411 - Active, not recruiting
  Pneumococcal Infections
  
• Study to Evaluate Four Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as One Dose to Children Aged 12 to 14 Months and 3 to 5 Years Old
  ClinicalTrials.gov Identifier: NCT00126984 - Active, not recruiting
  Meningitis, Meningococcal
  
• Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
  ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
  Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
  
• Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
  ClinicalTrials.gov Identifier: NCT00329901 - Active, not recruiting
  Meningococcal Disease; Meningococcal Meningitis
  
• Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
  
• Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand
  ClinicalTrials.gov Identifier: NCT00255021 - Active, not recruiting
  Diphtheria; Tetanus; Poliomyelitis; Haemophilus Infections; Pertussis
  
• Evaluation of a Third and Fourth Dose of StaphVAX® in Adults with End-Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00130260 - Active, not recruiting
  Staphylococcal Infections; Chronic Kidney Failure
  
• Study Comparing a 13-Valent Pneumococcal Conjugate Vaccine With 23-Valent Polysaccharide Vaccine in Adults
  ClinicalTrials.gov Identifier: NCT00427895 - Active, not recruiting
  Pneumococcal Infections
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
  recurrent prostate cancer
  
• Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults
  ClinicalTrials.gov Identifier: NCT00440531 - Active, not recruiting
  Haemophilus Infections; Hepatitis B
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
  recurrent prostate cancer
  
• Study of Long-Term Antibody Persistence After a Booster Dose of Menitorix Vaccine
  ClinicalTrials.gov Identifier: NCT00454987 - Active, not recruiting
  Meningococcal Infections; Haemophilus Infections
  
• Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
  ClinicalTrials.gov Identifier: NCT00030823 - Active, not recruiting
  Breast Cancer; Male Breast Cancer
  
• Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00277147 - Active, not recruiting
  Typhoid Fever
  
• Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00521586 - Recruiting
  Influenza
  
• Study Evaluating 13vPnC in People 50-59 Years of Age
  ClinicalTrials.gov Identifier: NCT00488852 - Active, not recruiting
  Pneumococcal Conjugate Vaccine
  
• Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00488826 - Completed
  Vaccines, Pneumococcal Conjugate Vaccine
  
• Long-Term Antibody Persistence at 1, 3 and 5 Years After a Booster Dose of Hib-MenCY-TT Vaccine Compared to ActHIB
  ClinicalTrials.gov Identifier: NCT00359983 - Active, not recruiting
  Haemophilus Infections; Meningococcal Infections
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003224 - Active, not recruiting
  Stage IV Melanoma; stage II melanoma; stage III melanoma; Recurrent Melanoma
  
• Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
  ClinicalTrials.gov Identifier: NCT00496015 - Active, not recruiting
  Fever
  
• Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00036933 - Active, not recruiting
  stage III prostate cancer; recurrent prostate cancer
  
• Study in Adolescents/Adults to Evaluate Non-Inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00356369 - Active, not recruiting
  Meningococcal Infections
  
• Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00071955 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants.
  ClinicalTrials.gov Identifier: NCT00366340 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Study to Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants
  ClinicalTrials.gov Identifier: NCT00366548 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants
  ClinicalTrials.gov Identifier: NCT00366678 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Infants
  ClinicalTrials.gov Identifier: NCT00366899 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants.
  ClinicalTrials.gov Identifier: NCT00368966 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants
  ClinicalTrials.gov Identifier: NCT00384059 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Wyeth Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants
  ClinicalTrials.gov Identifier: NCT00464945 - Active, not recruiting
  Pneumococcal Vaccines
  
• Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00474539 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in India
  ClinicalTrials.gov Identifier: NCT00452790 - Active, not recruiting
  Pneumococcal Infections
  
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age
  ClinicalTrials.gov Identifier: NCT00489554 - Active, not recruiting
  Pneumococcal Diseases
  
• Effect of Meningococcal Conjugate Vaccine On Meningococcal Carriage
  ClinicalTrials.gov Identifier: NCT00119080 - Completed
  Meningitis
  
• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ 10-Valent Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00344318 - Active, not recruiting
  Pneumococcal Infections
  
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ 10-Valent Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00345358 - Active, not recruiting
  Pneumococcal Infections
  
• Study to Evaluate the Safety and Immunogenicity of a 10-Valent Pneumococcal Conjugate Vaccine in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00390910 - Active, not recruiting
  Pneumococcal Infections
  
• Primary & Booster Immunogenicity Study of GSK Biologicals’ Hib-MenC Versus a Licensed Men-C Vaccine
  ClinicalTrials.gov Identifier: NCT00258700 - Completed
  H.Influenzae Type b Diseases; Meningococcal Serogroup C Diseases
  
• Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants
  ClinicalTrials.gov Identifier: NCT00213265 - Active, not recruiting
  Organ Transplant; Immunosuppression
  
• Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children
  ClinicalTrials.gov Identifier: NCT00311415 - Active, not recruiting
  Prevention of Meningococcal Infection
  
• Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age
  ClinicalTrials.gov Identifier: NCT00329849 - Active, not recruiting
  Meningococcal Disease
  
• A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers
  ClinicalTrials.gov Identifier: NCT00384397 - Active, not recruiting
  Meningococcal Meningitis; Measles; Mumps; Rubella; Varicella
  
• Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children
  ClinicalTrials.gov Identifier: NCT00452452 - Active, not recruiting
  Pneumococcal Infections
  
• Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
  ClinicalTrials.gov Identifier: NCT00258856 - Active, not recruiting
  Meningitis; Meningococcal Infection
  
• Safety and Immunogenicity of Chiron Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.
  ClinicalTrials.gov Identifier: NCT00310817 - Active, not recruiting
  Meningococcal Meningitis
  
• Evaluate the Safety & Immunogenicity of GSK Biologicals’ 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule
  ClinicalTrials.gov Identifier: NCT00307034 - Active, not recruiting
  Pneumococcal Infections
  
• Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults
  ClinicalTrials.gov Identifier: NCT00450437 - Active, not recruiting
  Meningococcal Disease; Meningococcal Meningitis
  
• Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea
  ClinicalTrials.gov Identifier: NCT00219401 - Recruiting
  Pneumonia; Meningitis; Otitis Media
  
• Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00320463 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Influenza Type b Disease
  
• Pilot Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00579423 - Active, not recruiting
  Prostate; Cancer
  
• Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)
  ClinicalTrials.gov Identifier: NCT00161122 - Recruiting
  recurrent upper and lower respiratory tract infections (RTIs)